GLOBUS MEDICAL INC - Class A Stock (GMED)

Historical Holders from Q1 2014 to Q3 2025

Symbol: GMED on NYSE
Type / Class: Equity / Class A Stock
Shares outstanding: 115,244,363
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 115,853,147
Holdings value: $6,650,083,414
% of all portfolios: 0.01%
Number of holders: 484
Number of buys: 245
Number of sells: -244
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of GLOBUS MEDICAL INC - Class A Stock (GMED)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	9.1%	+16.2%	$778,991,964	-$11,095,352	10,487,237	-1.4%	BlackRock, Inc.	31 Mar 2025
JANUS HENDERSON GROUP PLC	6.1%	+5%	$522,135,958	+$30,787,723	7,029,294	+6.27%	JANUS HENDERSON GROUP PLC	31 Mar 2025

Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	115,853,147	$6,650,083,414	+$67,502,073	$2,051,658	$15,846,609	$57.27	484
2025 Q2	114,075,801	$6,730,550,265	+$195,769,879	$1,322,048	$28,659,504	$59.02	477
2025 Q1	109,345,858	$7,997,914,722	-$8,993,495	$4,220,455	$13,389,700	$73.20	507
2024 Q4	108,904,887	$9,007,980,911	+$44,310,752	$10,744,029	$24,175,493	$82.71	495
2024 Q3	108,072,594	$7,734,964,942	-$332,078,125	$3,383,842	$13,048,975	$71.54	444
2024 Q2	112,764,178	$7,722,959,830	-$3,143,182	$2,773,845	$12,978,855	$68.49	443
2024 Q1	113,402,229	$6,082,679,016	+$359,376,321	$5,444,460	$11,446,776	$53.64	435
2023 Q4	106,692,854	$5,685,431,048	-$155,605,070	$3,549,114	$24,694,586	$53.29	405
2023 Q3	109,414,808	$5,433,176,387	+$1,362,204,600	$3,906,214	$14,542,485	$49.65	426
2023 Q2	81,374,906	$4,843,899,307	+$408,515,363	$821,652	$19,451,718	$59.54	378
2023 Q1	74,600,238	$4,224,726,594	-$151,471,403	$4,389,600	$30,884,704	$56.64	381
2022 Q4	75,948,098	$5,639,196,814	+$86,702,611	$1,180,893	$13,584,029	$74.27	383
2022 Q3	74,451,382	$4,436,437,568	+$100,448,577	$875,000	$8,149,000	$59.57	356
2022 Q2	72,222,203	$4,054,750,490	+$112,004,727	$1,428,722	$8,258,528	$56.14	349
2022 Q1	69,530,797	$5,130,106,470	+$81,009,114	$5,114,000	$18,526,000	$73.78	366
2021 Q4	68,345,177	$4,935,105,853	+$7,508,095	$15,278,000	$24,340,000	$72.20	367
2021 Q3	67,700,811	$5,190,187,299	-$70,035,321	$5,385,000	$23,155,000	$76.62	380
2021 Q2	68,045,932	$5,276,020,366	+$27,082,820	$1,931,000	$21,392,000	$77.53	351
2021 Q1	67,739,467	$4,178,223,997	+$52,788,626	$3,722,000	$11,621,000	$61.67	338
2020 Q4	66,616,139	$4,344,582,646	+$137,526,882	$11,445,000	$20,127,000	$65.22	343
2020 Q3	64,418,606	$3,189,910,125	-$115,537,152	$9,226,000	$21,612,000	$49.52	336
2020 Q2	66,705,847	$3,180,329,751	-$236,172,306	$13,093,000	$15,792,000	$47.71	312
2020 Q1	71,806,963	$3,053,523,816	+$121,157,476	$12,686,000	$11,542,000	$42.53	266
2019 Q4	67,279,881	$3,960,808,169	-$28,832,985	$14,688,000	$13,104,000	$58.88	304
2019 Q3	68,078,022	$3,478,746,497	+$23,175,292	$3,659,000	$6,348,000	$51.12	266
2019 Q2	67,934,676	$2,873,736,931	+$68,262,206	$15,008,000	$2,821,000	$42.30	255
2019 Q1	66,704,822	$3,293,778,190	-$65,694,730	$4,619,000	$4,185,000	$49.41	264
2018 Q4	68,249,962	$2,953,271,922	+$98,486,796	$1,892,000	$3,900,000	$43.28	301
2018 Q3	65,487,760	$3,715,590,483	+$107,199,480	$9,342,000	$7,304,000	$56.76	310
2018 Q2	63,650,675	$3,211,939,865	+$91,311,533	$17,690,000	$11,383,000	$50.46	285
2018 Q1	61,964,717	$3,079,267,072	-$55,501,163	$4,265,000	$1,385,000	$49.82	276
2017 Q4	63,316,479	$2,600,052,259	-$177,983,391	$2,589,000	$8,241,000	$41.10	254
2017 Q3	68,779,684	$2,044,301,959	+$133,468,390	$698,000	$12,301,000	$29.72	247
2017 Q2	63,912,936	$2,113,531,840	-$6,742,413	$0	$204,000	$33.15	240
2017 Q1	66,448,625	$1,968,206,890	+$212,215,068	$898,000	$3,270,000	$29.62	240
2016 Q4	66,416,082	$1,647,898,444	+$49,757,687	$615,000	$4,259,000	$24.81	204
2016 Q3	65,110,721	$1,468,682,032	-$90,108,711	$934,000	$9,039,000	$22.57	191
2016 Q2	68,944,209	$1,642,903,804	+$5,899,417	$2,497,000	$7,037,000	$23.83	203
2016 Q1	69,470,642	$1,648,818,412	+$41,022,318	$4,857,000	$2,371,000	$23.75	200
2015 Q4	66,193,785	$1,841,465,465	+$9,162,505	$81,000	$2,368,000	$27.82	185
2015 Q3	66,646,506	$1,376,939,977	+$85,476,007	$60,000	$1,084,000	$20.66	178
2015 Q2	62,535,892	$1,605,270,230	-$1,848,789	$580,000	$316,000	$25.67	177
2015 Q1	62,724,615	$1,582,790,729	+$33,704,934	$4,972,000	$687,000	$25.24	178
2014 Q4	61,313,895	$1,457,510,086	+$92,436,342	$3,530,000	$578,000	$23.77	181
2014 Q3	57,176,622	$1,124,529,205	+$35,352,082	$248,000		$19.67	163
2014 Q2	54,426,902	$1,301,914,540	+$4,051,848			$23.92	174
2014 Q1	53,176,394	$1,411,676,236	+$60,435,010			$26.59	157